|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.170 CNY | -4.67% |
|
-8.31% | -15.77% |
| Market Cap | 3.67B 542M 476M 443M 406M 763M 52.17B 775M 5.25B 2.05B 25.65B 2.03B 1.99B 88.69B | P/E 2024 |
35.9x | P/E 2025 | 88.2x |
|---|---|---|---|---|---|
| Enterprise Value | 2.92B 432M 379M 352M 323M 608M 41.56B 617M 4.19B 1.64B 20.43B 1.62B 1.59B 70.64B | EV / Sales 2024 |
7.4x | EV / Sales 2025 | 8.08x |
| Free-Float |
24.34% | Yield 2024 |
0.62% | Yield 2025 | 0.36% |
| 1 day | -4.67% | ||
| 1 week | -8.31% | ||
| Current month | +8.64% | ||
| 1 month | +7.64% | ||
| 3 months | -10.22% | ||
| 6 months | -23.43% | ||
| Current year | -15.77% |
| 1 week | 8.1 |  | 9.11 |
| 1 month | 7.02 | | 9.88 |
| Current year | 7.02 | | 10.89 |
| 1 year | 7.02 | | 13.28 |
| 3 years | 6.3 | | 14.55 |
| 5 years | 6.3 | | 28 |
| 10 years | 6.3 | | 28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Jie Guo
CEO | Chief Executive Officer | 53 | 06/04/2023 |
Yi Ming Wu
DFI | Director of Finance/CFO | 57 | 30/04/2025 |
Hui Zhang
IRC | Investor Relations Contact | 44 | 31/05/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Jun Ye
CHM | Chairman | 53 | 18/08/2020 |
Xiao Ming Ying
BRD | Director/Board Member | 58 | 01/08/2012 |
Yong Lü
BRD | Director/Board Member | 69 | 18/08/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.67% | -8.31% | -31.00% | -35.06% | 542M | |
| -0.66% | +0.44% | +14.72% | +76.40% | 48.36B | |
| +2.20% | +1.41% | +61.04% | +111.43% | 35.8B | |
| +1.26% | -0.57% | -5.20% | +34.48% | 11.83B | |
| -0.46% | -3.06% | +14.15% | +80.63% | 11.48B | |
| -0.37% | -0.37% | +37.89% | +137.78% | 9.01B | |
| +1.52% | +0.39% | +48.79% | -5.82% | 6.99B | |
| -0.17% | -2.92% | +13.13% | +30.45% | 6.7B | |
| -0.59% | -1.95% | +2.23% | +178.07% | 6.42B | |
| -7.92% | -13.61% | -34.97% | -4.08% | 5.3B | |
| Average | -0.99% | -2.75% | +12.08% | +60.43% | 14.24B | |
| Weighted average by Cap. | +0.10% | -0.48% | +25.14% | +80.92% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 512M 75.56M 66.36M 61.72M 56.63M 106M 7.28B 108M 733M 286M 3.58B 284M 278M 12.37B | 447M 65.95M 57.93M 53.87M 49.43M 92.88M 6.35B 94.31M 640M 250M 3.12B 248M 242M 10.8B |
| Net income | 128M 18.86M 16.56M 15.4M 14.14M 26.56M 1.82B 26.97M 183M 71.47M 893M 70.8M 69.27M 3.09B | 47.48M 7.01M 6.16M 5.73M 5.26M 9.88M 675M 10.03M 68.02M 26.57M 332M 26.33M 25.76M 1.15B |
| Net Debt | -734M -108M -95.15M -88.49M -81.2M -153M -10.43B -155M -1.05B -411M -5.13B -407M -398M -17.73B | -746M -110M -96.82M -90.04M -82.63M -155M -10.62B -158M -1.07B -418M -5.22B -414M -405M -18.05B |
Employees
319
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | CN¥8.170 | -4.67% | 4,238,515 |
| 23/07/26 | CN¥8.570 | -2.61% | 5,084,639 |
| 22/07/26 | CN¥8.800 | +1.15% | 6,056,048 |
| 21/07/26 | CN¥8.700 | -2.58% | 6,585,768 |
| 20/07/26 | CN¥8.930 | +0.22% | 6,744,829 |
- Stock Market
- Stocks
- 688247 Stock
Select your edition
All financial news and data tailored to specific country editions
